Revenue
No reported data
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $9.8M | $9.4M | $15.5M | $9.0M | $8.4M | $5.1M |
| Operating income | −$19.9M | −$15.6M | −$22.8M | −$17.5M | −$20.7M | −$7.1M |
| Net income | −$22.4M | −$16.6M | −$23.5M | −$17.7M | −$20.7M | −$7.2M |
| Basic EPSper diluted share | -$4.44 | -$10.86 | -$311.99 | -$29.35 | -$2.79 | — |
| Diluted EPSper diluted share | -$4.44 | -$10.86 | -$311.99 | -$29.35 | -$2.79 | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 13, 2026Form 4 | Hargroves Thomas JeffreyDirector | BuyCommon Stock · indirect | 97.3K | $5.04 | $490.3K | 97.5K |
| Feb 13, 2026Form 4 | Hargroves Thomas JeffreyDirector | BuyWarrant to Purchase Common Stock · derivative · indirect | 77.8K | $0.10 | $7.8K | 77.8K |
| Feb 6, 2026Form 4 | Werth Peter J.Director | BuyCommon Stock · indirect | 19.5K | $5.04 | $98.1K | 117.4K |
| Feb 6, 2026Form 4 | Werth Peter J.Director | BuyWarrant to Purchase Common Stock · derivative · indirect | 15.6K | $0.10 | $1.6K | 15.6K |
| Feb 6, 2026Form 4 | Callahan Jennifer L.SVP and CFO | BuyCommon Stock | 4.9K | $5.04 | $24.5K | 5.1K |